Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs.Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 18, 2022 | Grant | €2.50M | 1 | European Innovation Council | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Grant |